Literature DB >> 29153846

Surgical management of neurological manifestations of mucopolysaccharidosis disorders.

Tord D Alden1, Hernán Amartino2, Amauri Dalla Corte3, Christina Lampe4, Paul R Harmatz5, Leonardo Vedolin6.   

Abstract

The mucopolysaccharidosis (MPS) disorders are ultra-rare lysosomal storage disorders associated with progressive accumulation of glycosaminoglycans (GAGs) in cells and tissues throughout the body. Clinical manifestations and progression rates vary widely across and within the different types of MPS. Neurological symptoms occur frequently, and may result directly from brain damage caused by infiltration of GAGs, or develop secondary to somatic manifestations such as spinal cord compression, hydrocephalus, and peripheral nerve entrapment. Management of secondary neurological manifestations often requires surgical correction of the underlying somatic cause. The present review discusses the surgical management of neurological disease in patients with MPS, including diagnostic imaging. Background information is derived from presentations and discussions during a meeting on the brain in MPS, attended by an international group of experts (April 28-30, 2016, Stockholm, Sweden), and additional literature searches.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diagnostic imaging; Hydrocephalus; Mucopolysaccharidosis; Neurological disease; Spinal cord compression; Surgery

Mesh:

Substances:

Year:  2017        PMID: 29153846     DOI: 10.1016/j.ymgme.2017.09.011

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  7 in total

1.  General Anesthesia Management for Adult Mucopolysaccharidosis Patients Undergoing Major Spine Surgery.

Authors:  Masahiko Tsuchiya; Hidetomi Terai; Koh Mizutani; Yusuke Funai; Katsuaki Tanaka; Tokuhiro Yamada; Takashi Mori; Kiyonobu Nishikawa
Journal:  Med Princ Pract       Date:  2019-09-03       Impact factor: 1.927

2.  Spinal cord compression in patients with mucopolysaccharidosis.

Authors:  Tobias Pantel; Mona Lindschau; Andreas M Luebke; Philip Kunkel; Marc Dreimann; Nicole Muschol; Sven O Eicker
Journal:  Eur Spine J       Date:  2022-03-10       Impact factor: 2.721

Review 3.  Surgical Management of Spinal Disorders in People with Mucopolysaccharidoses.

Authors:  Hidetomi Terai; Hiroaki Nakamura
Journal:  Int J Mol Sci       Date:  2020-02-10       Impact factor: 5.923

4.  Adjunct diagnostic value of radiological findings in mucopolysaccharidosis type IVa-related thoracic spinal abnormalities: a pilot study.

Authors:  Ya-Ting Jan; Pei-Shan Tsai; Wen-Hui Huang; Shih-Chieh Huang; Yu-Peng Liu; She-Meng Cheng; Kun-Shuo Huang
Journal:  Orphanet J Rare Dis       Date:  2022-07-29       Impact factor: 4.303

5.  Critical clinical situations in adult patients with Mucopolysaccharidoses (MPS).

Authors:  Karolina M Stepien; Anait K Gevorkyan; Christian J Hendriksz; Tinatin V Lobzhanidze; Jordi Pérez-López; Govind Tol; Mireia Del Toro Riera; Nato D Vashakmadze; Christina Lampe
Journal:  Orphanet J Rare Dis       Date:  2020-05-14       Impact factor: 4.123

6.  Craniosynostosis affects the majority of mucopolysaccharidosis patients and can contribute to increased intracranial pressure.

Authors:  Esmee Oussoren; Irene M J Mathijssen; Margreet Wagenmakers; Rob M Verdijk; Hansje H Bredero-Boelhouwer; Marie-Lise C van Veelen-Vincent; Jan C van der Meijden; Johanna M P van den Hout; George J G Ruijter; Ans T van der Ploeg; Mirjam Langeveld
Journal:  J Inherit Metab Dis       Date:  2018-08-06       Impact factor: 4.982

Review 7.  Non-cardiac Manifestations in Adult Patients With Mucopolysaccharidosis.

Authors:  Karolina M Stepien; Andrew Bentley; Cliff Chen; M Wahab Dhemech; Edward Gee; Peter Orton; Catherine Pringle; Jonathan Rajan; Ankur Saxena; Govind Tol; Chaitanya Gadepalli
Journal:  Front Cardiovasc Med       Date:  2022-03-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.